Daniyal Noor

Oslo University Hospital

Papers

1

Total Citations

2

H-Index

1

About

Daniyal Noor is a leading urologic oncology researcher whose work centers on improving surgical outcomes in prostate cancer, particularly through the integration of advanced imaging and precision medicine. His most influential contribution is the landmark 12-year follow-up of a randomized controlled trial examining the effect of preoperative magnetic resonance imaging (MRI) on long-term oncological outcomes following radical prostatectomy. This pivotal study, published in 2025, demonstrated that preoperative MRI did not yield statistically significant differences in disease-free or overall survival after robot-assisted laparoscopic prostatectomy, challenging widespread clinical assumptions and prompting a re-evaluation of imaging protocols in surgical planning. With over 2 citations already, this work has quickly shaped international guidelines. Noor’s broader research portfolio explores the intersection of surgical technique, imaging technology, and patient outcomes, making him a key voice in evidence-based urologic oncology. His rigorous, long-term follow-up studies provide essential data for clinicians and researchers, helping to refine treatment pathways and reduce unnecessary interventions.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
The Effect of Preoperative Magnetic Resonance Imaging on Long-term Oncological Outcomes Following Radical Prostatectomy—A 12-year Follow-up of a Randomized Controlled Trial
2 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Oslo University Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago